Nexavar is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Sorafenib.
| Product ID | 50419-488_20ab7dba-4d59-4221-ad33-2dc86cd4f4e5 |
| NDC | 50419-488 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nexavar |
| Generic Name | Sorafenib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2005-12-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021923 |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | SORAFENIB |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2005-12-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021923 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-20 |
| Ingredient | Strength |
|---|---|
| SORAFENIB | 200 mg/1 |
| SPL SET ID: | b50667e4-5ebc-4968-a646-d605058dbef0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50419-488 | Nexavar | sorafenib |
| 0480-5425 | Sorafenib | Sorafenib |
| 24979-715 | Sorafenib | Sorafenib |
| 43598-458 | sorafenib | sorafenib |
| 51990-201 | Sorafenib | Sorafenib |
| 0378-1201 | Sorafenib Tosylate | Sorafenib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NEXAVAR 78670152 3537095 Live/Registered |
Bayer Aktiengesellschaft 2005-07-14 |
![]() NEXAVAR 75943985 2745627 Live/Registered |
Bayer Aktiengesellschaft 2000-03-14 |